Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy

Published: Nov. 25, 2020, 5 a.m.

Host: Marianne J. Davies, DNP, ACNP, AOCNP
Guest: Julie R. Brahmer, MD, MSc

Immune-related adverse events (IRAEs) pose significant hurdles in achieving optimal responses to immune checkpoint inhibitors and represent a clinical challenge for healthcare professionals. Join Drs. Marianne Davies and Julie Brahmer as they discuss the importance of improving clinician awareness and competence in providing timely intervention for IRAEs.